524703 SANDUPHQ

Sandu Pharmaceuticals

₹56.79
-0.61 (-1.06%)
23 November, 2024 15:17 BSE: 524703 NSE: SANDUPHQISIN: INE751D01014

Start SIP in Sandu Pharmaceuticals

Start SIP

Sandu Pharmaceuticals Performance

Day Range

₹ 56

52 Week Range

₹ 56

Sandu Pharmaceuticals Share Price

  • Over 1 Month +0.75%
  • Over 3 Month -6.32%
  • Over 6 Month -6.29%
  • Over 1 Year -19.28%

Sandu Pharmaceuticals Key Statistics

Sandu Pharmaceuticals Technicals

EMA & SMA

Current Price
₹56.79
-0.61 (-1.06%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹57.42
  • 50 Day
  • ₹58.37
  • 100 Day
  • ₹59.50
  • 200 Day
  • ₹60.89
  • 20 Day
  • ₹56.81
  • 50 Day
  • ₹59.02
  • 100 Day
  • ₹59.86
  • 200 Day
  • ₹61.56

Sandu Pharmaceuticals Resistance and Support

PIVOT
₹56.81
Resistance
First Resistance 57.62
Second Resistance 58.45
Third Resistance 59.26
RSI 46.39
MFI 59.11
MACD Single Line -0.40
MACD -0.24
Support
First Support 55.98
Second Support 55.17
Third Supoort 54.34

Sandu Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,084 81,202 74.91
Week 1,467 111,532 76.04
1 Month 5,444 405,544 74.5
6 Month 10,392 772,682 74.35

Sandu Pharmaceuticals Result Highlights

Sandu Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sandu Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-12 Quarterly Results & Final Dividend
2024-06-05 Audited Results (Revised) per share(5%)Dividend
2024-03-30 Others Inter alia, to consider : 1. To Consider and Appoint Chief Financial Officer of the Company. per share(5%)Dividend
2024-02-14 Quarterly Results

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91